On the assessment of adverse drug reactions from spontaneous reporting systems: The influence of under-reporting on odds ratios

Statistics in Medicine

Volumn 21, Issue 14, 2002, Pages 2027-2044

  Van Der Heijden, Peter G M ^a,b   Van Puijenbroek, Eugène P ^c   Van Buuren, Stef ^a   Van Der Hofstede, Jacques W ^a  

^a TNO   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

Author keywords

Adverse drug reactions; Pharmacovigilance; Spontaneous reporting system; Under reporting

Indexed keywords

ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; DICLOFENAC; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TERBINAFINE;

ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COVARIANCE; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; DRUG SURVEILLANCE PROGRAM; EDEMA; FEMALE; HAIR LOSS; HUMAN; INFORMATION PROCESSING; MALE; RISK ASSESSMENT; SEX DIFFERENCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DIURETICS; DRUG INTERACTIONS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PRODUCT SURVEILLANCE, POSTMARKETING; SEX FACTORS;

EID: 0037199381     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1157     Document Type: Article

References (26)

1. The detection of adverse reactions to therapeutic drugs
2. Statistical logic in the monitoring of reactions to therapeutic drugs
3. Systemic signalling of adverse reactions to drugs
4. Responding to drug safety issues
5. Analysis of the information in a central ADE database
6. Signaling possible drug-drug interactions in a spontaneous reporting system: Delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole
7. Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: An example with diuretics and non-steroidal anti-inflammatory drugs
8. A regionalized spontaneous surveillance program for adverse drug reactions as a tool to improve pharmacotherapy
9. Estimation of underreporting
10. Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System
11. Alert systems for post-marketing surveillance of adverse drug reactions
12. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trend in total reporting
13. Underreporting of suspected adverse drug reactions to newly marketed ('black triangle') drugs in general practice: Observational study
14. Attitudinal survey of voluntary reporting of adverse drug reactions
15. Serum sickness-like reactions to Cefaclor
16. Non-puerperal lactation associated with antidepressant drug use
17. Pharmacovigilance: A science or fielding emergencies
18. Transformation of a database of spontaneously reported suspected adverse drug reactions and its use as a tool in signal detection. Pharmacoepidemiological approached to the evaluation of antidepressant drugs
19. Is reporting rate a good predictor of risks associated with drugs?
20. Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure
21. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics
22. Adverse reactions to nonsteroidal anti-inflammatory drugs. Diclofenac compared with other nonsteroidal anti-inflammatory drugs
23. Treatment of onychomycosis with terbinafine